SureTrader
Home > Boards > US Listed > Cannabis > GW Pharmaceuticals Plc ADS (GWPH)

I sold most of my call options today

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
fung_derf Member Profile
Member Level 
Followed By 178
Posts 101,016
Boards Moderated 14
Alias Born 08/30/01
160x600 placeholder
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the Treatment of Le... "PR Newswire (US)" - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Le... "GlobeNewswire Inc." - 12/29/2017 7:00:00 AM
GW Pharmaceuticals Announces Acceptance of NDA Filing for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndro... "GlobeNewswire Inc." - 12/28/2017 7:00:00 AM
GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors "GlobeNewswire Inc." - 12/21/2017 7:00:00 AM
Biotech Market Banking on Big Cannabis Returns "NetworkNewsWire" - 12/19/2017 8:45:00 AM
Dangerous Opioid Side Effects Shift Market Focus to Cannabis for Chronic Pain "NetworkNewsWire" - 12/13/2017 8:45:00 AM
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S. "GlobeNewswire Inc." - 12/13/2017 7:00:00 AM
GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exe... "GlobeNewswire Inc." - 12/11/2017 5:19:05 PM
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $276 Million "GlobeNewswire Inc." - 12/6/2017 9:40:30 PM
Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management "NetworkNewsWire" - 12/6/2017 8:45:00 AM
GW Pharmaceuticals Announces Proposed Public Offering of ADSs "GlobeNewswire Inc." - 12/5/2017 4:01:00 PM
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress "GlobeNewswire Inc." - 12/4/2017 7:00:00 AM
Investors Could Reap Global Rewards of Research into Medical Cannabis Science "NetworkNewsWire" - 11/30/2017 8:45:00 AM
GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 4 December, 2017 "GlobeNewswire Inc." - 11/27/2017 7:00:00 AM
GW Pharmaceuticals to Present at Upcoming Investor Conferences "GlobeNewswire Inc." - 11/22/2017 7:00:00 AM
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Epidiolex® (cannabidiol) Data and Educational Progra... "GlobeNewswire Inc." - 11/21/2017 7:00:00 AM
Innovation Drives Value for Leading Cannabis Biotechs "NetworkNewsWire" - 11/15/2017 8:45:00 AM
Biotech M&A Momentum Attractive for Cannabinoid R&D Space "NetworkNewsWire" - 11/7/2017 8:45:00 AM
Bioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, Medication "NetworkNewsWire" - 11/2/2017 8:45:00 AM
Economic Impact of Biosynthesis on the Cannabis Industry "NetworkNewsWire" - 10/31/2017 8:45:00 AM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug Application Submission to U.S. Fo... "GlobeNewswire Inc." - 10/30/2017 7:00:00 AM
Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products "NetworkNewsWire" - 10/26/2017 8:45:00 AM
How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals "NetworkNewsWire" - 10/24/2017 8:45:00 AM
Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development "NetworkNewsWire" - 9/28/2017 8:45:00 AM
Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development "NetworkNewsWire" - 9/26/2017 8:45:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist